urea has been researched along with leukotriene b4 in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 7 (87.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blom-Bülow, B; Linden, M; Schmekel, B; Venge, P; Wollmer, P | 1 |
Feinstein, MB; Molski, TF; Naccache, PH; Sha'afi, RI; Shefcyk, J; Tao, W; Volpi, M; White, JR; Yassin, R | 1 |
Adams, JL; Breton, JJ; Chabot-Fletcher, MC; Griswold, DE; Hay, DW; Kagey-Sobotka, A; Marshall, LA; Sarau, HM; Underwood, DC; Winkler, JD | 1 |
Fuller, BJ; Green, CJ; Lane, NJ; Manek, S; Thorniley, MS | 1 |
Adams, JL; Albrightson, CR; Brickson, B; Dytko, G; Griswold, DE; Short, B; Zabko-Potapovich, B | 1 |
Awni, WM; Braeckman, RA; Dubé, LM; Granneman, GR; Witt, G | 1 |
Anderson, J; Chen, E; Shamsuddin, M; Smith, LJ | 1 |
Cai, X; Eckman, J; Hussoin, MS; Hwang, SB; Ip, SH; Killian, DB; Libertine-Garahan, L; Qian, C; Scannell, RT; Shen, TY; Yaeger, D; Yeh, CG | 1 |
1 trial(s) available for urea and leukotriene b4
Article | Year |
---|---|
Pharmacokinetics and pharmacodynamics of zileuton after oral administration of single and multiple dose regimens of zileuton 600mg in healthy volunteers.
Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Circadian Rhythm; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Fasting; Humans; Hydroxylation; Hydroxyurea; Leukotriene B4; Lipoxygenase Inhibitors; Male; Middle Aged; Stereoisomerism; Urea; White People | 1995 |
7 other study(ies) available for urea and leukotriene b4
Article | Year |
---|---|
Transfer of 99mTc DTPA and bronchoalveolar lavage findings in patients with asymptomatic extrinsic allergic alveolitis.
Topics: Adult; Albumins; Alveolitis, Extrinsic Allergic; Bronchoalveolar Lavage Fluid; Eosinophils; Humans; Leukotriene B4; Macrophages; Male; Middle Aged; Organotechnetium Compounds; Pentetic Acid; Pulmonary Alveoli; Respiratory Function Tests; Technetium Tc 99m Pentetate; Time Factors; Urea | 1990 |
Effects of chemotactic factors and other agents on the amounts of actin and a 65,000-mol-wt protein associated with the cytoskeleton of rabbit and human neutrophils.
Topics: Actins; Aminoquinolines; Animals; Arachidonic Acid; Arachidonic Acids; Calcimycin; Cytoskeleton; Glucose; Humans; Leukotriene B4; Molecular Weight; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Rabbits; Tetradecanoylphorbol Acetate; Urea; Water-Electrolyte Balance | 1985 |
Pharmacological characterization of SB 202235, a potent and selective 5-lipoxygenase inhibitor: effects in models of allergic asthma.
Topics: Animals; Antigens; Asthma; Benzofurans; Bronchoconstriction; Disease Models, Animal; Eosinophils; Guinea Pigs; Humans; Hypersensitivity; In Vitro Techniques; Leukotriene B4; Lipoxygenase Inhibitors; Trachea; Urea | 1995 |
Inhibition of leukotriene B4 synthesis does not prevent development of acute renal failure following storage and transplantation.
Topics: Acute Kidney Injury; Animals; Capillary Permeability; Creatinine; Disease Models, Animal; Eicosanoids; Enzyme-Linked Immunosorbent Assay; Female; Graft Rejection; Graft Survival; Hydroxylamines; Hydroxyurea; Kidney Transplantation; Kidney Tubules; Leukotriene B4; Lipoxygenase Inhibitors; Methylurea Compounds; Necrosis; Organ Preservation; Prostaglandins F; Rabbits; Thromboxane B2; Urea | 1994 |
Selective inhibition of 5-lipoxygenase attenuates glomerulonephritis in the rat.
Topics: Animals; Arachidonate 5-Lipoxygenase; Basement Membrane; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Glomerular Filtration Rate; Glomerulonephritis; Immunoglobulin G; Kidney Glomerulus; Leukotriene B4; Lipoxygenase Inhibitors; Male; Rats; Rats, Sprague-Dawley; Sheep; Tetrahydronaphthalenes; Urea | 1994 |
Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages.
Topics: Acetyltransferases; Acyl-Carrier Protein S-Acetyltransferase; Arachidonic Acids; Asthma; Benzenesulfonates; Bronchoalveolar Lavage Fluid; Calcimycin; Calcium; Cells, Cultured; Cytosol; Enzyme Inhibitors; Humans; Ionophores; Leukotriene B4; Leukotrienes; Macrophages, Alveolar; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Tetradecanoylphorbol Acetate; Urea | 1997 |
(+/-)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and platelet-activating factor receptor antagonist.
Topics: Animals; Arachidonic Acid; Blood Platelets; Cell Membrane; CHO Cells; Cricetinae; Drug Evaluation, Preclinical; Edema; Enzyme Inhibitors; Furans; Hematocrit; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Mice; Platelet Membrane Glycoproteins; Rats; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship; Tetradecanoylphorbol Acetate; Tumor Cells, Cultured; Urea | 1998 |